VCU researchers developing affordable, noninvasive treatment for RDS in newborns
Worth Longest and his team received a $3 million grant to create an aerosolized surfactant - a substance that lowers liquid surface tension - and a device to deliver it
VCU Engineering faculty among world’s most-cited researchers in 2022, according to Stanford University study
A study from Elsevier BV, based at Stanford University, finds that 17 VCU College of Engineering professors are in the world’s top 2% of most-cited researchers in 2022.
Researchers explore alternate delivery method for potential Alzheimer’s treatment
Researchers at Virginia Commonwealth University’s College of Engineering and School of Pharmacy are working toward a proof of concept for a nose-to-brain delivery system of insulin to treat Alzheimer’s patients.
Innovation Gateway supports six new projects with the Commercialization Fund
Funding helps VCU faculty innovators move their research closer to the marketplace.
Worth Longest research on more targeted aerosol drug delivery systems
As a Minnesota biotech company chases life-saving applications for their research, two VCU professors press forward on their work to use aerosols — tiny particles released into the airways — to deliver advanced drugs to those in need.
20 VCU Engineering faculty among world’s most-cited researchers in 2021, according to Stanford University study
VCU Engineering faculty are among the world's most-cited researchers.
VCU Engineering-led team receives FDA funding to develop new methods for evaluating the performance of generic nasal sprays for children
Laleh Golshahi, Ph.D., an assistant professor in VCU’s Department of Mechanical and Nuclear Engineering, is leading a multidisciplinary team that received a $1.6 million, three-year contract from the U.S. Food and Drug Administration (FDA) to develop physical and computer-based models to evaluate the performance of generic and brand-name nasal spray medications used by children.
Mechanical and nuclear engineering researcher wins funding to expand global access to respiratory medicines for infants
Worth Longest, Ph.D., is principal investigator on a project to improve the way infants in respiratory distress receive life saving surfactant, a substance found in healthy lungs that keeps the tissue supple enough to expand and contract properly.
